FFPE

The Fix-C method is a modified version of Hi-C and makes use of the fact that the structural information relevant in cancer is preserved in FFPE samples.

Dust off the Samples

UK researchers have dug into the archive to find more cancer samples for sequencing, Nature News reports.

The company plans to outlicense the assay, developed using a custom Affymetrix microarray, to an interested partner.

Two researchers devised a protocol to sequence DNA from ancient samples and tested it on 100-year-old museum specimens.

The combination of the new test with Biocartis' existing KRAS assay offers customers a complete solution for testing metastatic colorectal cancers as reccomended by professional guidelines.

The company plans to raise $25 million in a Series B financing round. It is also working on a two-color chemistry and aims to develop an instrument for clinical applications.

The diagnostic, a real-time PCR kit for breast cancer stratification, is being reviewed under a special process for the approval of innovative products.

Earlier this month at AGBT, company researchers presented the new developments, which Thermo Fisher plans to roll out later this year.

They plan to combine Silicon’s DEPArray digital-sorting technology with Macrogen’s NGS systems to develop genomic tests for different cancers.

At the Festival of Genomics conference, experts discussed ongoing issues with developing NGS tests for the clinic, and how they are solving such challenges. 

Pages

A new analysis examines the gender gap among paper authors in the sciences and says it may take decades or more to close.

Researchers have uncovered signals of selection that may enable the Bajau people to free five hundreds of feet deep, Reuters reports.

In Science this week: paternally inherited cis-regulatory structural variants in autism, and more.

A new report outlines issues facing the implementation of personalized medicine in the UK, the Independent reports.